| Name | ZEB1 antisense RNA 1 |
| Description | This locus produces long non-coding RNA that is transcribed from a shared bi-directional promoter with zinc finger E-box binding homeobox 1 (ZEB1). This transcript binds lysine methyltransferase 2A and promotes histone modifications that are thought to promote expression of ZEB1. Expression of this gene is correlated with tumor progression. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2017] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe long noncoding RNA ZEB1‐AS1, which is transcribed from the promoter region of the ZEB1 gene, is emerging as a critical oncogenic regulator across a broad spectrum of human malignancies. Studies have demonstrated that its expression is markedly upregulated in cancers such as glioma, osteosarcoma, bladder, colorectal, esophageal, hepatocellular, gastric, pancreatic, prostate, melanoma, lung cancer, and even in hematological malignancies like B‐lineage acute lymphoblastic leukemia. In many of these studies, high ZEB1‐AS1 levels correlate with advanced clinical stage, enhanced metastasis, and poor overall prognosis, suggesting that this lncRNA plays a key role in disease progression and may function as a prognostic biomarker."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "20"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nMechanistic investigations have revealed that ZEB1‐AS1 exerts its oncogenic functions by regulating gene expression at multiple levels. Functioning as a competitive endogenous RNA (ceRNA), it “sponges” a variety of tumor‐suppressive microRNAs (for example, members of the miR‐200 family, miR‐181a‐5p, miR‐342‐3p, miR‐505, miR‐299‐3p, miR‐23c, among others), thereby de‐repressing key targets such as ZEB1, TRIB2, CUL4B, and E2F1. In addition, ZEB1‐AS1 can interact with RNA‐binding proteins like ELAVL1, AUF1, and STAT3 to enhance mRNA stability, establishing positive feedback loops that further increase ZEB1 expression. Through these interactions, the lncRNA promotes epithelial‐to‐mesenchymal transition (EMT) and activates oncogenic signaling cascades—including the PI3K/AKT/mTOR and TGF‐β/Smad pathways—that drive cell cycle progression, invasion, and metastasis."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "21", "end_ref": "32"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nCollectively, these studies underscore that deregulation of ZEB1‐AS1 contributes to tumorigenesis—not only by enhancing proliferation, migration, invasion, and chemoresistance but also by modulating key processes such as apoptosis and ferroptosis. Moreover, its aberrant expression in select nonmalignant conditions (e.g., atherosclerosis) and even in certain neurodegenerative contexts further highlights the multifaceted role of ZEB1‐AS1 in disease pathogenesis. As such, ZEB1‐AS1 represents a promising prognostic biomarker and an attractive therapeutic target, warranting further investigation into its potential for clinical intervention.\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Qiao-Li Lv, Lei Hu, Shu-Hui Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms17091431"}], "href": "https://doi.org/10.3390/ijms17091431"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27589728"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27589728"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Chibo Liu, Chunqin Pan, Yanqun Cai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interplay Between Long Noncoding RNA ZEB1-AS1 and miR-200s Regulates Osteosarcoma Cell Proliferation and Migration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.25879"}], "href": "https://doi.org/10.1002/jcb.25879"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28075045"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28075045"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Junhao Lin, Yonghao Zhan, Yuchen Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.15527"}], "href": "https://doi.org/10.18632/oncotarget.15527"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28445936"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28445936"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Huangbo Gong, Hao Wen, Xuhui Zhu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "High expression of long non-coding RNA ZEB1-AS1 promotes colorectal cancer cell proliferation partially by suppressing p15 expression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Tumour Biol (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1010428317705336"}], "href": "https://doi.org/10.1177/1010428317705336"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28618933"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28618933"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Wenjing Su, Miao Xu, Xueqin Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA ZEB1-AS1 epigenetically regulates the expressions of ZEB1 and downstream molecules in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-017-0711-y"}], "href": "https://doi.org/10.1186/s12943-017-0711-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28830551"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28830551"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Qing Wang, Xiaoli Du, Min Yang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ZEB1-AS1 contributes to STAT3 activation by associating with IL-11 in B-lymphoblastic leukemia."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biotechnol Lett (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s10529-017-2421-3"}], "href": "https://doi.org/10.1007/s10529-017-2421-3"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28861713"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28861713"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Jining Fu, Yongyuan Cui "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA ZEB1-AS1 expression predicts progression and poor prognosis of colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Biol Markers (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.5301/ijbm.5000303"}], "href": "https://doi.org/10.5301/ijbm.5000303"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28967064"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28967064"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "X-J Liu, S-L Li, J-S Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA ZEB1-AS1 is associated with poor prognosis in gastric cancer and promotes cancer cell metastasis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201805_14956"}], "href": "https://doi.org/10.26355/eurrev_201805_14956"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29771411"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29771411"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Y-G Zhang, M-W Zhou, L Bai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Extracellular vesicles promote esophageal cancer progression by delivering lncZEB1-AS1 between cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Rev Med Pharmacol Sci (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.26355/eurrev_201805_14962"}], "href": "https://doi.org/10.26355/eurrev_201805_14962"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29771414"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29771414"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Chaojie Liang, Jing Liu, Hua Ge, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The clinicopathological and prognostic value of long non-coding RNA ZEB1-AS1 in solid tumors: A meta-analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Chim Acta (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cca.2018.05.011"}], "href": "https://doi.org/10.1016/j.cca.2018.05.011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29778540"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29778540"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Chunye Chen, Yan Feng, Xing Wang "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ZEB1-AS1 expression in cancer prognosis: Review and meta-analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Chim Acta (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cca.2018.06.007"}], "href": "https://doi.org/10.1016/j.cca.2018.06.007"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29885321"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29885321"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Shao-Yan Lv, Ti-Dong Shan, Xin-Ting Pan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The lncRNA ZEB1-AS1 sponges miR-181a-5p to promote colorectal cancer cell proliferation by regulating Wnt/β-catenin signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Cycle (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1080/15384101.2018.1471317"}], "href": "https://doi.org/10.1080/15384101.2018.1471317"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29886791"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29886791"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Jianjun Jin, Huanqin Wang, Jiming Si, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ZEB1-AS1 is associated with poor prognosis in non-small-cell lung cancer and influences cell migration and apoptosis by repressing ID1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Sci (Lond) (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1042/CS20180983"}], "href": "https://doi.org/10.1042/CS20180983"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30626729"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30626729"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Haina Chai, Chao Sun, Jun Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Relationship Between ZEB1-AS1 Expression and the Prognosis of Patients With Advanced Gastric Cancer Receiving Chemotherapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Technol Cancer Res Treat (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1177/1533033819849069"}], "href": "https://doi.org/10.1177/1533033819849069"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31072267"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31072267"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Xin Zhao, Dongwen Wang, Yongxue Ding, et al. "}, {"type": "b", "children": [{"type": "t", "text": "lncRNA ZEB1-AS1 promotes migration and metastasis of bladder cancer cells by post-transcriptional activation of ZEB1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijmm.2019.4187"}], "href": "https://doi.org/10.3892/ijmm.2019.4187"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31115480"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31115480"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Ádamo Davi Diógenes Siena, Jéssica Rodrigues Plaça, Luiza Ferreira Araújo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Whole transcriptome analysis reveals correlation of long noncoding RNA ZEB1-AS1 with invasive profile in melanoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41598-019-47363-6"}], "href": "https://doi.org/10.1038/s41598-019-47363-6"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31383874"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31383874"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Yan Zhao, Ning Wang, Xiaosan Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ZEB1-AS1 down-regulation suppresses the proliferation and invasion by inhibiting ZEB1 expression in oesophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/jcmm.14692"}], "href": "https://doi.org/10.1111/jcmm.14692"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31638344"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31638344"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Xin Ni, Yuting Ding, Haitao Yuan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA ZEB1-AS1 promotes colon adenocarcinoma malignant progression via miR-455-3p/PAK2 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Prolif (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cpr.12723"}], "href": "https://doi.org/10.1111/cpr.12723"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31828845"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31828845"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Na Luo, Kejing Zhang, Xin Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ZEB1 induced-upregulation of long noncoding RNA ZEB1-AS1 facilitates the progression of triple negative breast cancer by binding with ELAVL1 to maintain the stability of ZEB1 mRNA."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Biochem (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jcb.29572"}], "href": "https://doi.org/10.1002/jcb.29572"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31922280"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31922280"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Zhaohui Hua, Ke Ma, Shirui Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ZEB1-AS1 facilitates ox-LDL-induced damage of HCtAEC cells and the oxidative stress and inflammatory events of THP-1 cells via miR-942/HMGB1 signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Life Sci (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.lfs.2020.117334"}], "href": "https://doi.org/10.1016/j.lfs.2020.117334"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31962131"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31962131"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Mingwen Jiao, Shanglei Ning, Jingbo Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non‑coding RNA ZEB1‑AS1 predicts a poor prognosis and promotes cancer progression through the miR‑200a/ZEB1 signaling pathway in intrahepatic cholangiocarcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Oncol (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3892/ijo.2020.5023"}], "href": "https://doi.org/10.3892/ijo.2020.5023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32236578"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32236578"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Teng Ma, Hua Chen, Peilong Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Downregulation of lncRNA ZEB1-AS1 Represses Cell Proliferation, Migration, and Invasion Through Mediating PI3K/AKT/mTOR Signaling by miR-342-3p/CUL4B Axis in Prostate Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Biother Radiopharm (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1089/cbr.2019.3123"}], "href": "https://doi.org/10.1089/cbr.2019.3123"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32275162"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32275162"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Guohua Wei, Ting Lu, Jian Shen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ZEB1-AS1 promotes pancreatic cancer progression by regulating miR-505-3p/TRIB2 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2020.05.105"}], "href": "https://doi.org/10.1016/j.bbrc.2020.05.105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32513531"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32513531"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Sixiang Cheng, Shengyu Guo, Hairong He, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical value of long noncoding RNA ZEB1 anti-sense1 in cancer patients: A meta-analysis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Medicine (Baltimore) (2020)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/MD.0000000000021307"}], "href": "https://doi.org/10.1097/MD.0000000000021307"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "32756112"}], "href": "https://pubmed.ncbi.nlm.nih.gov/32756112"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Chencheng Dai, Pengfei Xu, Siyu Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA ZEB1-AS1 affects paclitaxel and cisplatin resistance by regulating MMP19 in epithelial ovarian cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Arch Gynecol Obstet (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s00404-020-05858-y"}], "href": "https://doi.org/10.1007/s00404-020-05858-y"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33151424"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33151424"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Baiyin Mu, Chenlan Lv, Qingli Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long non-coding RNA ZEB1-AS1 promotes proliferation and metastasis of hepatocellular carcinoma cells by targeting miR-299-3p/E2F1 axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biochem (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/jb/mvab042"}], "href": "https://doi.org/10.1093/jb/mvab042"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33788950"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33788950"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Difang Chen, Kunwei Wang, Yan Zheng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosomes-Mediated LncRNA ZEB1-AS1 Facilitates Cell Injuries by miR-590-5p/ETS1 Axis Through the TGF-β/Smad Pathway in Oxidized Low-density Lipoprotein-induced Human Umbilical Vein Endothelial Cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cardiovasc Pharmacol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/FJC.0000000000000974"}], "href": "https://doi.org/10.1097/FJC.0000000000000974"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33818551"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33818551"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Shuai Xue, Fengqin Lu, Chunhui Sun, et al. "}, {"type": "b", "children": [{"type": "t", "text": "LncRNA ZEB1-AS1 regulates hepatocellular carcinoma progression by targeting miR-23c."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "World J Surg Oncol (2021)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12957-021-02176-8"}], "href": "https://doi.org/10.1186/s12957-021-02176-8"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "33865414"}], "href": "https://pubmed.ncbi.nlm.nih.gov/33865414"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Federica Rey, Erika Maghraby, Letizia Messa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of a novel pathway in sporadic Amyotrophic Lateral Sclerosis mediated by the long non-coding RNA ZEB1-AS1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neurobiol Dis (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.nbd.2023.106030"}], "href": "https://doi.org/10.1016/j.nbd.2023.106030"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "36736597"}], "href": "https://pubmed.ncbi.nlm.nih.gov/36736597"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Soudeh Ghafouri-Fard, Arian Askari, Kimia Behzad Moghadam, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A review on the role of ZEB1-AS1 in human disorders."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pathol Res Pract (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.prp.2023.154486"}], "href": "https://doi.org/10.1016/j.prp.2023.154486"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37120907"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37120907"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Chen Wu, Xinfang Hou, Shuai Li, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Long noncoding RNA ZEB1-AS1 attenuates ferroptosis of gastric cancer cells through modulating miR-429/BGN axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biochem Mol Toxicol (2023)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/jbt.23381"}], "href": "https://doi.org/10.1002/jbt.23381"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "37128782"}], "href": "https://pubmed.ncbi.nlm.nih.gov/37128782"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Nianxi Tan, Junyi Tang, Guang Chen, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ZEB1-AS1 mediates bone metastasis through targeting miR-320b/BMPR1A axis in lung cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Respir J (2024)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/crj.13770"}], "href": "https://doi.org/10.1111/crj.13770"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "38783645"}], "href": "https://pubmed.ncbi.nlm.nih.gov/38783645"}]}]}]}
|
| NCBI Gene ID | 220930 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
ZEB1-AS1 has 1,800 functional associations with biological entities spanning 6 categories (molecular profile, organism, disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 22 datasets.
Click the + buttons to view associations for ZEB1-AS1 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of ZEB1-AS1 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of ZEB1-AS1 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of ZEB1-AS1 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of ZEB1-AS1 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of ZEB1-AS1 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at ZEB1-AS1 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of ZEB1-AS1 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of ZEB1-AS1 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of ZEB1-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of ZEB1-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of ZEB1-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of ZEB1-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of ZEB1-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of ZEB1-AS1 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of ZEB1-AS1 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of ZEB1-AS1 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of ZEB1-AS1 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of ZEB1-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of ZEB1-AS1 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of ZEB1-AS1 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of ZEB1-AS1 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at ZEB1-AS1 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |